In subanalyses examining the impact of CH on cardiovascular outcomes for specific cancers, we found that the presence of CHIP mutations was linked to adverse cardiovascular events and increased mortality in women diagnosed with breast cancer and corpus uteri cancer. This evidence concerns the gene STUB1 and cyclic hematopoiesis.